• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX SANTA ROSA ALTO; MAIN BODY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX SANTA ROSA ALTO; MAIN BODY Back to Search Results
Model Number TV-AB2980-N
Device Problems Partial Blockage (1065); Fluid/Blood Leak (1250); Material Invagination (1336); Material Integrity Problem (2978)
Patient Problems Cardiac Arrest (1762); Low Blood Pressure/ Hypotension (1914); Failure of Implant (1924); Vomiting (2144); Obstruction/Occlusion (2422); Thrombosis/Thrombus (4440)
Event Date 01/26/2022
Event Type  Death  
Manufacturer Narrative
The device remains implanted in the patient; therefore, it will not be returned for evaluation.Patient medical records and imaging studies will be requested for further evaluation by the clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.Device remains implanted.
 
Event Description
The patient was being implanted with the alto abdominal stent graft system to treat an abdominal aortic aneurysm (aaa).Four (4) minutes after polymer fill of the aortic body stent graft, the polymer syringe was observed to have emptied and the patient experienced hypotension evidenced by a drop in blood pressure due to a suspected polymer leak.The patient was successfully treated for an anaphylactic reaction per the device ifu.The procedure was successfully completed with no endoleak.The patient was being monitored.Additional information was provided from the physician a few days later.The physician stated that the patient seemed to recover well from the anaphylactic reaction.However, when attempting to extubate the patient, the patient aspirated (while vomiting) and required to be reintubated.On sunday or monday (january 30 or 31), a new ct (computed tomography) scan was taken.The ct showed that the aortic body was occluded.Early monday morning, (b)(6) 2022, the patient was taken back to the operating room.The physician preformed a bi-lateral open femoral artery exposure.The physician removed thrombus from both limbs and the aortic body as it appears to be occluded.The physician stated that the proximal rings of the stent graft seemed to be enfolded.The physician ballooned the rings and they seemed to open well.Flow was noted to be good.The physician started to patch the femoral artery before closing the contralateral side.At this point, the patient spontaneously coded.Attempts to revive the patient were made.Unfortunately, the patient passed on monday ((b)(6) 2022) morning.
 
Manufacturer Narrative
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.An evaluation of the device could not be completed.The device was report as not being available to be returned to endologix for an evaluation.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix was unable to confirm the reported hypotension caused by a possible polymer leak, polymer ring in-folding or the additional endovascular procedure.The aortic occlusion that occurred 5 days post the initial procedure was confirmed.This is moderately consistent with the reported adverse event/incident.Device, user, procedure or anatomy relatedness of this complaint could not be determined with the medical records available for review.The procedure related harms identified were the aortic occlusion.It was reported the patient recovered well from the hypotension caused by a possible polymer leak but aspirated during extubation requiring re-intervention the evening of the index procedure.The patient was reported to have passed away on (b)(6) 2022.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALTO
Type of Device
MAIN BODY
Manufacturer (Section D)
ENDOLOGIX SANTA ROSA
3910 brickway blvd
santa rosa CA 95403
Manufacturer (Section G)
ENDOLOGIX SANTA ROSA
3910 brickway blvd
,
santa rosa CA 95403
Manufacturer Contact
gary kirchgater
3910 brickway blvd
,
santa rosa, CA 95403
8009832284
MDR Report Key13527671
MDR Text Key285600411
Report Number3008011247-2022-00009
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00850007370909
UDI-Public(01)00850007370909(17)241203(10)FS113021-11
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P120006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional,Company Representative
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date 01/26/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberTV-AB2980-N
Device Lot NumberFS113021-11
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/26/2022
Initial Date FDA Received02/14/2022
Supplement Dates Manufacturer Received03/14/2022
Supplement Dates FDA Received04/11/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/28/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
FILL POLYMER, LOT FF081621-02; OVATION IX, ILIAC LIMB, LOT FS112421-39; OVATION IX, ILIAC LIMB, LOT FS113021-05
Patient Outcome(s) Death;
Patient Age76 YR
Patient SexMale
-
-